Exprimo is a company that focuses on the application of population pharmacokinetics (PK), drug-disease modeling, and simulation. It develops Simulo, a clinical trial tool performing Monte Carlo simulations, evaluating study designs, and comparing dosing strategies. The company aims to support decision making in drug development.